Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University., Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Review.

2.

Effect of sertraline on proliferation and neurogenic differentiation of human adipose-derived stem cells.

Razavi S, Jahromi M, Amirpour N, Khosravizadeh Z.

Adv Biomed Res. 2014 Mar 25;3:97. doi: 10.4103/2277-9175.129367.

3.

Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters.

Ricci LA, Morrison TR, Melloni RH Jr.

Horm Behav. 2012 Nov;62(5):569-78. doi: 10.1016/j.yhbeh.2012.09.007.

4.

Psychopharmacology of anxiety disorders.

Cassano GB, Baldini Rossi N, Pini S.

Dialogues Clin Neurosci. 2002 Sep;4(3):271-85.

5.

Venlafaxine in the treatment of panic disorder.

Katzman MA, Jacobs L.

Neuropsychiatr Dis Treat. 2007 Feb;3(1):59-67.

6.

Pharmacotherapy of panic disorder.

Pull CB, Damsa C.

Neuropsychiatr Dis Treat. 2008 Aug;4(4):779-95.

7.
8.

From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples.

Lydiard RB, Perera P, Batzar E, Clary CM.

Prim Care Companion J Clin Psychiatry. 1999 Oct;1(5):154-162.

9.

Anxiety disorders.

Chen JP, Reich L, Chung H.

West J Med. 2002 Sep;176(4):249-53. Review. No abstract available.

Items per page

Supplemental Content

Support Center